Pentraxin 3 is considered an important inflammatory marker is known to increase
in patients with ischemic stroke, but the relationship between pentraxin 3 and
intracerebral hemorrhage mortality is unclear. The purpose of this study is to investigate
the level of pentraxin 3 in serum and its impact on prognosis in 307 patients
with intracerebral hemorrhage. During the 5-year follow-up, the mortality rate of
patients with intracerebral hemorrhage was 22.5%. The serum pentraxin 3
level of the brain-dead patients was higher than that of the control group
(P
